Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Respirology (Carlton, Vic.)|November 30, 2013
Rituximab in severe, treatment-refractory interstitial lung diseaseGregory J Keir, Toby M Maher, Damien Ming, et al.
The Journal of Rheumatology|February 5, 2013
Serum interleukin 6 is predictive of early functional decline and mortality in interstitial lung disease associated with systemic sclerosisAngelo De Lauretis, Piersante Sestini, Panagiotis Pantelidis, et al.
Clinical Rheumatology|January 10, 2020
Defining genetic risk factors for scleroderma-associated interstitial lung disease : IRF5 and STAT4 gene variants are associated with scleroderma while STAT4 is protective against scleroderma-associated interstitial lung diseaseCarmel J W Stock, Angelo De Lauretis, Dina Visca, et al.
Respirology (Carlton, Vic.)|December 18, 2020
Serum markers of pulmonary epithelial damage in systemic sclerosis-associated interstitial lung disease and disease progressionCarmel J W Stock, Rachel K Hoyles, Cecile Daccord, et al.
The European Respiratory Journal|April 18, 2020
Pleuroparenchymal fibroelastosis in systemic sclerosis: prevalence and prognostic impactMartina Bonifazi, Nicola Sverzellati, Eva Negri, et al.
American Journal of Respiratory and Critical Care Medicine|April 24, 2018
Predicting Outcomes in Idiopathic Pulmonary Fibrosis Using Automated Computed Tomographic AnalysisJoseph Jacob, Brian J Bartholmai, Srinivasan Rajagopalan, et al.
The Lancet. Respiratory Medicine|September 2, 2018
Effect of ambulatory oxygen on quality of life for patients with fibrotic lung disease (AmbOx): a prospective, open-label, mixed-method, crossover randomised controlled trialDina Visca, Letizia Mori, Vicky Tsipouri, et al.
The European Respiratory Journal|October 12, 2023
Long-term outcomes of the global tuberculosis and COVID-19 co-infection cohort, Nicolas Casco, Alberto Levi Jorge, et al.
Pageof 2